Author: Ken Dropiewski

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

FDA Approved, Resolute Onyx 2.0 mm DES Technology Tackles Clinical Challenge of Treating Coronary Artery Disease in Previously Untreatable Patients DUBLIN – February 26, 2018 – Designed specifically for small vessels, Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute […]

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to host EPLive 2018

AUSTIN, Texas, Feb. 26, 2018 /PRNewswire/ — On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center will host its fourth international symposium on complex arrhythmias, EPLive 2018. EPLive is an intensive, two-day educational meeting for practicing clinical cardiac electrophysiologists, electrophysiologist fellows and […]

NaviGate Cardiac Structures Inc. (“NCSI”) reports GATE™ bioprosthesis as the first transcatheter valve replacement in Canada to treat tricuspid regurgitation

LAKE FOREST, Calif.–(BUSINESS WIRE)–NaviGate Cardiac Structures Inc. (“NCSI”) announced today that on 2 Feb. 2018, its catheter-guided GATE™ valved-stent bioprosthesis beame the first Canadian orthotopic valve replacement to treat severe tricuspid regurgitation. The procedure was performed at the Quebec Heart and Lung Institute, Laval University (Quebec City, Canada) by the Institute’s […]

Vascular Graft Solutions: External Stenting of Vein Grafts is Associated With High Early Patency Rates

TEL AVIV, Israel, Feb. 23, 2018 /PRNewswire/ — Vascular Grafts Solutions announced today the interim results from the VEST III study, a post-marketing trial which evaluates the effectiveness of the VEST technology (Venous External SupporT) in treatment of saphenous vein graft (SVG) disease after coronary artery bypass grafting. The Interim […]

Access Vascular Receives FDA Clearance For Its HydroPICC Catheter

BEDFORD, Mass., Feb. 22, 2018 /PRNewswire/ — Access Vascular, a medical device company reinventing venous access using proprietary material technology designed to reduce thrombus accumulation, announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its lead product, the HydroPICC™, a peripherally inserted central catheter, […]

John McDermott Steps Down as Chief Executive Officer of Endologix, Inc.

IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott is stepping down as the Company’s Chief Executive Officer. To facilitate a smooth transition, Mr. McDermott has committed to remaining in his current role until a successor is found. Daniel T. […]

Delray Beach Medical Center Performs First Robotic-Assisted Peripheral Vascular Intervention Using Corindus CorPath® GRX System Following FDA Clearance

WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics (Formerly known as Corindus), Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today the successful completion of the first robotic-assisted peripheral vascular intervention procedure using the recently FDA-cleared CorPath GRX System. The procedure was performed by Joseph Ricotta, M.D., Medical Director […]

Tricuspid Valve Repair Company 4Tech Inc. Appoints Tom Fleming as President and CEO, and Dr. Keith Dawkins as CMO

GALWAY, Ireland–(BUSINESS WIRE)– 4Tech Inc., a leader in the field of transcatheter tricuspid valve repair, announces changes in its leadership team: Tom Fleming will join the company as President and Chief Executive Officer (CEO), effective as of March 2018; and Keith D. Dawkins, M.D., has joined as Chief Medical Officer (CMO), effective immediately. Tom […]

Study Validates New Approach for Optimizing Endovascular Drug Delivery Using Stents with a Deployable Coating That Enhances Sirolimus Distribution Compared to Traditional DES

“This preclinical demonstration that stent deployment of microcrystalline drug in combination with a rapidly absorbable polymer, such as with MiStent, results in more uniform drug dosing that could lead to more rapid and uniform healing across the treated segment,” said David Kandzari, M.D., Director of Interventional Cardiology and Chief Scientific Officer, Piedmont […]

PQ Bypass Announces First Patient Treated in Landmark DETOUR II Trial Evaluating New Treatment Approach for Clogged Leg Arteries

SUNNYVALE, Calif.–(BUSINESS WIRE)– PQ Bypass, a clinical-stage medical technology company that has developed the DETOUR procedure, a novel treatment for long (>15 cm) superficial femoral artery (SFA) blockages, announced enrollment of the first patients in the pivotal DETOUR II Trial in the United States. The trial is a prospective, single-arm clinical […]